Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed (ND) or recurrent/refractory (R/R) glioblastoma (GBM); Phase 1B/2 study update Meeting Abstract


Authors: Piotrowski, A.; Puduvalli, V.; Wen, P.; Colman, H.; Campian, J.; Pearlman, M.; Butowski, N.; Cloughesy, T.; Battiste, J.; Glass, J.; Schiff, D.; van den Bent, M.; Walbert, T.; Ahluwalia, M.; Badruddoja, M.; Kalra, A.; Pelham, R.; Zhang, K.; Wood, K.; Weller, M.; Shih, K.
Abstract Title: Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed (ND) or recurrent/refractory (R/R) glioblastoma (GBM); Phase 1B/2 study update
Meeting Title: 25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 22
Issue: Suppl. 2
Meeting Dates: 2020 Nov 19-21
Meeting Location: Virtual Conference
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2020-11-01
Start Page: ii51
Language: English
ACCESSION: WOS:000590061300206
PROVIDER: wos
DOI: 10.1093/neuonc/noz175.081
Notes: Meeting Abstract: CTNI-38 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors